Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors

Sales & Marketing Executive Brings Global Expertise in Global Channel Marketing MIRAMAR, FL, April 08, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology...
March 12, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces the Appointment of Chief Commercial Officer

Lance Goudzwaard Appointed to Head Commercialization and Customer Relations for NuGenerex Distribution Solutions Subsidiary MIRAMAR, FL, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE –...
March 01, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Investor Conference Call Now Available Online

MIRAMAR, FL, March 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
February 26, 2019 08:00 ET | Source: Generex Biotechnology Corp.

Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details

MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
February 15, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern

Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology MIRAMAR, FL, Feb. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
January 29, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces Investor Conference Call Scheduled for February 26, 2019

Management to Provide Details on NuGenerex Immuno-Oncology: Dividend, New Acquisitions, IP Licensing Opportunities, and Strategic Plans for Public Listing Acquisition, Integration of Fuse...
January 14, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans

MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the...